Vineet Laboratories (NSE:VINEETLAB) Notes Receivable: ₹0.0 Mil (As of Dec. 2025)


NSE:VINEETLAB Vineet Laboratories Ltd NSE:VINEETLAB
38 GF Score
Price ₹33.26
GF Value ₹15.37
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Vineet Laboratories Notes Receivable?

Vineet Laboratories NSE:VINEETLAB -1.63% 38 Notes Receivable is ₹0.0 Mil as of Dec. 2025. GuruFocus rates NSE:VINEETLAB with a GF Score™ of 38/100 and a GF Value™ of ₹15.37 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Vineet Laboratories's Notes Receivable for the quarter that ended in Dec. 2025 was ₹0.0 Mil.

Vineet Laboratories Notes Receivable Related Terms

Vineet Laboratories Notes Receivable Historical Data

* Premium members only.

The historical data trend for Vineet Laboratories's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vineet Laboratories Notes Receivable Chart

Vineet Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vineet Laboratories Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:VINEETLAB
38GF Score
Vineet Laboratories Ltd NSE:VINEETLAB
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vineet Laboratories Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0.0 Mil mean?
Vineet Laboratories (NSE:VINEETLAB) has a Notes Receivable of ₹0.0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Vineet Laboratories and its competitors.
Is Vineet Laboratories' Notes Receivable too high?
Vineet Laboratories' current Notes Receivable is ₹0.0 Mil. Overall, Vineet Laboratories has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vineet Laboratories' Notes Receivable compare to DOW?
Vineet Laboratories' Notes Receivable of ₹0.0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Chemicals company?
A good Notes Receivable depends on the Chemicals industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Vineet Laboratories and its competitors. Vineet Laboratories's current Notes Receivable is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vineet Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vineet Laboratories (NSE:VINEETLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹15.37, compared to a current price of ₹33.26 — trading 116.4% above its estimated fair value. The current Notes Receivable is ₹0.0 Mil. Vineet Laboratories' overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Vineet Laboratories (NSE:VINEETLAB), the current Notes Receivable is ₹0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued. The current stock price of ₹33.26 is trading 116.4% above its estimated GF Value™ of ₹15.37. GuruFocus considers Vineet Laboratories to be Significantly Overvalued.

Key valuation signals for NSE:VINEETLAB:

  • Notes Receivable: ₹0.0 Mil
  • GF Value™: ₹15.37 vs. price of ₹33.26 (116.4% above fair value)
  • GF Score™: 38/100 with 6 warning signs

No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vineet Laboratories Business Description

Other Exchanges 543298:India
Address 5-5-160, Malleswari Nilayam, Chintalakunta, Opposite Vishnu Theatre, L.B Nagar, Hyderabad, TG, IND, 500074
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
38GF Score

Get the complete analysis for NSE:VINEETLAB

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹33.26
Price
₹15.37
GF Value